Zai Lab Limited (ZLAB) Tops Q1 EPS by 38c

Zai Lab Limited (NASDAQ: ZLAB) reported Q1 EPS of ($0.55), $0.38 better than the analyst estimate of ($0.93). Revenue for the quarter came in at $87.1 million versus the consensus estimate of $73.99 million.

For earnings history and earnings-related data on Zai Lab Limited (ZLAB) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
• Marpai, Inc. (MRAI) Misses Q2 EPS by 18c